Dr. Reddy's Laboratories is recalling numerous lots of generic Zantac, known as Ranitidine (150 mg and 300 mg capsules and tablets), sold under various brand names such as Walgreens, Walmart, CVS, and Target. The recall was initiated because testing detected the presence of N-Nitrosodimethylamine (NDMA), an impurity that is classified as a probable human carcinogen. Consumers should contact their healthcare provider or pharmacist to discuss alternative treatments and return any unused medication to the pharmacy for a refund.
The medication contains NDMA, a substance that may cause cancer in humans based on laboratory testing. Long-term exposure to levels above acceptable limits increases the risk of developing cancer.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.